David and Beatrix Hamburg Award for Advances in Biomedical Research and Clinical Medicine
The David and Beatrix Hamburg Award for Advances in Biomedical Research and Clinical Medicine will be presented annually by the National Academy if Medicine to recognize creative and accomplished biomedical scientists who are advancing health and the human condition around the world.
Named for David Hamburg, who was president of the Institute of Medicine from 1975-1980, and Beatrix Hamburg, an NAM member and expert in child and adolescent behavioral health, this new award is accompanied by a medal and $50,000. The award will be funded by an endowment that was established in 2004 in honor of the Hamburgs’ life and legacy. The award is now open for its first round of applications, and the first awardee will be named at the NAM’s Annual Meeting in October 2022.
Click here for Selection Criteria
Each year, a selection committee appointed by the National Academy of Medicine considers the following criteria when determining the winner of the Hamburg Award. The Hamburg Award is awarded to one or more scientists in recognition of an exceptional biomedical research discovery and/or translation that has fundamentally enriched our understanding of human biology and disease, leading to a significant reduction of disease burden and improvement in human health.
Principal selection criteria
- Discovery, translation, or public health intervention of impact which has led to improvement in human health and/or reduction in health inequities; and
- Innovative, creative, and pioneering achievement; and
- The nominee(s)’ unique contributions to the achievement
- Achievement was not previously recognized by a substantive international award
Additional selection criteria
- Demonstration of a qualitative and quantitative impact on health disparities
- Interdisciplinary science and collaborations are positively viewed
“I am so pleased that this award has been created in my parents’ name, and will honor their legacy and commitment to excellence and innovation in biomedical sciences. My parents were both psychiatrists by training but throughout their careers fostered and supported advances in basic and clinical science, especially those that were accomplished in collaboration across fields of expertise and that worked to improve the human condition. I am very much looking forward to honoring individuals who have exhibited the potential to benefit humanity through this award, and encourage all who can to submit an application in January 2022.”
— Margaret “Peggy” Hamburg, vice president for biological programs and policies at the Nuclear Threat Initiative, and former international secretary of the NAM